| Bioactivity | Bepafant (Web2170) is a platelet-activating factor (PAF) antagonist that protects against anaphylactic lethality in active and passive anaphylaxis models in mice and guinea pigs in a dose-dependent manner and attenuates bronchoconstriction and blood pressure changes in anaphylaxis. |
| CAS | 114776-28-2 |
| Formula | C23H22ClN5O2S |
| Molar Mass | 467.97 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Effect of the hetrazepinoic platelet-activating factor antagonist Bepafant (WEB 2170) in models of active and passive anaphylaxis in mice and guinea pigs [2]. Compounds biologically similar to platelet activating factor are present in stored blood components |
Bepafant
CAS: 114776-28-2 F: C23H22ClN5O2S W: 467.97
Bepafant (Web2170) is a platelet-activating factor (PAF) antagonist that protects against anaphylactic lethality in acti
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.